4-1BB-mediated immunotherapy of rheumatoid arthritis.
Seo
Su K
SK
The Immunomodulation Research Center, University of Ulsan, 29 Mukeo-Dong, Nam-ku, Ulsan 680-749, Korea.
Choi
Jae H
JH
Kim
Young H
YH
Kang
Woo J
WJ
Park
Hye Y
HY
Suh
Jae H
JH
Choi
Beom K
BK
Vinay
Dass S
DS
Kwon
Byoung S
BS
D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology / Q000627:therapeutic use*; D015703:Antigens, CD; D001172:Arthritis, Rheumatoid / Q000276:immunology / Q000503:physiopathology / Q000628:therapy*; D018845:CD11 Antigens / Q000276:immunology; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D016827:CD8 Antigens / Q000276:immunology; D024043:Collagen Type II / Q000276:immunology; D017931:DNA Primers; D003713:Dendritic Cells / Q000276:immunology; D007150:Immunohistochemistry; D007167:Immunotherapy; D051379:Mice; D009000:Monocytes / Q000276:immunology; D017475:Receptors, Nerve Growth Factor / Q000276:immunology*; D018124:Receptors, Tumor Necrosis Factor / Q000276:immunology*; D020133:Reverse Transcriptase Polymerase Chain Reaction; D013154:Spleen / Q000276:immunology; D014366:Tryptophan Oxygenase / Q000276:immunology / Q000378:metabolism; D053261:Tumor Necrosis Factor Receptor Superfamily, Member 9
D000911:Antibodies, Monoclonal; D015703:Antigens, CD; D018845:CD11 Antigens; D016827:CD8 Antigens; D024043:Collagen Type II; D017931:DNA Primers; D017475:Receptors, Nerve Growth Factor; D018124:Receptors, Tumor Necrosis Factor; C505714:TNFRSF9 protein, human; C505715:Tnfrsf9 protein, mouse; D053261:Tumor Necrosis Factor Receptor Superfamily, Member 9; D014366:Tryptophan Oxygenase